MedPredict

MedPredict is a German biotechnology company specializing in predictive medicine and personalized oncology. Founded as a spin-off from the University Medical Center of the Johannes Gutenberg University Mainz, the company utilizes advanced machine learning and transcriptomic profiling to predict patient response to cancer therapies. Its primary focus is on identifying molecular signatures that correlate with the efficacy of specific treatments, such as chemotherapy, to help clinicians tailor therapeutic strategies for individual patients. By providing data-driven insights into therapy response, MedPredict aims to optimize treatment selection, reduce unnecessary side effects, and improve clinical outcomes in breast cancer and other oncological indications.